UPDATE 1-Bristol-Myers to pay $1.85 bln in cancer deal with Nektar
February 14, 2018 at 10:55 AM EST
Feb 14 (Reuters) - Bristol-Myers Squibb Co will pay Nektar Therapeutics $1.85 billion for a global development and profit-sharing deal on a promising Nektar cancer drug, the companies announced on Wednesday.